HLB THERAPEUTICS CO.,LTD.

Other languages HLB Therapeutics Co.,Ltd.

Equities

A115450

KR7115450009

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
9,340 ^KRW	-5.56%		-11.89%	+113.00%

Apr. 01	HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	CI
Mar. 18	HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
HLB Therapeutics Submits Phase 3 Protocol for Neurotrophic Keratopathy	22-09-27
HLB Therapeutics Signs Letter of Intent with Global Ophthalmology CRO for Two Phase 3 Clinical Trials in Neurotrophic Keratitis	22-07-18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW